HBW Advisory Services LLC Has $269,000 Stock Holdings in iShares Biotechnology ETF $IBB

Posted by Linda Flegge on Jul 16th, 2026

HBW Advisory Services LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 73.8% during the 1st quarter, Holdings Channel reports. The firm owned 1,594 shares of the financial services provider’s stock after selling 4,490 shares during the quarter. HBW Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $269,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the second quarter worth approximately $25,000. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $29,000. Copia Wealth Management acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. Finally, Caitlin John LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.7%

NASDAQ:IBB opened at $189.90 on Thursday. The company has a fifty day moving average of $177.00 and a 200-day moving average of $173.16. iShares Biotechnology ETF has a twelve month low of $128.84 and a twelve month high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.